IR serves as an important factor by stimulating hyperinsulinemia, which then triggers the phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin pathway in patients with CRC. The gene discussed is MTOR; the disease is colorectal carcinoma.